ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 963

Ectopic Lymphoid Tissue in the Lung Is Associated with Serum Rheumatoid Arthritis-Related Autoantibodies Even in Absence of Clinically Apparent Rheumatoid Arthritis

Lindsay E. Brown1, M. Kristen Demoruelle2, Mark C. Parish3, Marie L. Feser2, Peter B. Sachs4, David E. Heinz5, Carlyne D. Cool1 and Kevin D. Deane6, 1University of Colorado School of Medicine, Aurora, CO, 2Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 3Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO, 4Department of Radiology, University of Colorado School of Medicine, Aurora, CO, 5Pathology, University of Colorado School of Medicine, Aurora, CO, 6Division of Rheumatology, U Colo Denver, Aurora, CO

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: interstitial lung disease and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis I

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Lung disease has been associated with elevations of RA and Sjogren’s-related autoantibodies (Abs), even in the absence
of extrathoracic features of these diseases (Fischer
2010). In particular, in classifiable RA organized ectopic lymphoid tissue in
the lung has been associated with RA related Abs (Rangel-Moreno 2006). Herein
we examine the association of Abs and lung histopathology in subjects with RA
lung disease, as well as subjects with non-RA lung disease.

Methods: Using materials from the NIH’s Lung Tissue Resource
Consortium (LTRC) we evaluated lung tissue and matched serum samples from 75
subjects with lung disease who for clinical care required lung biopsy: 10
subjects with RA and interstitial lung disease (ILD), and 65 subjects with ILD
or emphysema in absence of RA based on evaluation at the time of lung biopsy.
Serum was tested for Abs CCP3.1, RF isotypes
IgA, IgM and IgG, and SSA
and SSB.
Lung tissue was evaluated by
microscopy (H&E) to determine the presence of organized ectopic lymphoid
tissue defined as germinal centers (GCs) by a pulmonary pathologist blinded to
subjects’ Ab status. Multivariate analyses were used
to determine associations of Abs and GCs.

Results: The
patients’ characteristics grouped based on the presence of GCs are presented in
the Table. RA was significantly associated with the presence of GCs, and there
was a trend towards increasing age being inversely associated with GCs; smoking
was not associated with the presence of GCs. In analyses adjusting for RA and
age, serum positivity for CCP3.1 was strongly associated with the presence of
GCs (OR 4.1, 95% CI 1.2-14.4; p=0.03). In adjusted analyses there were no
significant associations with RF’s or SSA/B with GCs as single Abs; however, an
increasing number of positive Abs was associated with GCs. Specifically, for
every increase by 1 in number of serum Abs (+), there was a 60% increase in risk
of having GCs (OR 1.6, 95% CI 1.1-2.4; p=0.03).

Conclusion: In
this unique sample set from the LTRC, we confirm a strong relationship between
serum Abs and the presence of organized ectopic lymphatic tissue/GCs in the
lung, even after adjusting for the presence of clinically apparent RA. The
strongest associations were observed for anti-CCP and increasing total number
of Abs. The findings suggest a mechanistic link between GCs in the lung and
circulating Abs, and in particular anti-CCP, that may be due to in-situ generation
of Abs within GCs in the lung or that circulating Abs perpetuate the immune
response by forming organized lymphoid tissue in the lung. Future studies
should assess these potential mechanisms as well as evaluate the potential that
Abs may be a marker for lung GCs that could be used to understand disease
prognosis and response to treatment.

Table. Characteristics of subjects with and without germinal centers

Germinal Center (+)

N=16

Germinal Center (-)

N=59

p-value

Age, median (range)

53 (40-73)

63 (40-80)

0.06

Female (%)

63%

56%

0.78

Non-Hispanic White (%)

75%

78%

0.20

Ever smoker (%)

75%

73%

1.00

Rheumatoid arthritis diagnosis (%)

31%

9%

0.03*

Autoantibodies

RF-IgA

25%

15%

0.46

RF-IgM

44%

10%

<0.01*

RF-IgG

38%

24%

0.34

CCP3.1

56%

22%

0.01*

SSA

13%

7%

0.60

SSB

6%

2%

0.38

Antibody Count

1.5 (0-5)

0 (0-6)

<0.01*

*In analyses adjusted for age and diagnosis of RA, CCP3.1 positivity and Antibody Count were significantly associated with the presence of Germinal Centers; however, RF-IgM was not. For CCP3.1 adjusted OR 4.08, 95% CI 1.16-14.37; p=0.03. For Antibody Count adjusted OR 1.59, 95% 1.06-2.40; p=0.03.


Disclosure: L. E. Brown, None; M. K. Demoruelle, None; M. C. Parish, None; M. L. Feser, None; P. B. Sachs, None; D. E. Heinz, None; C. D. Cool, None; K. D. Deane, None.

To cite this abstract in AMA style:

Brown LE, Demoruelle MK, Parish MC, Feser ML, Sachs PB, Heinz DE, Cool CD, Deane KD. Ectopic Lymphoid Tissue in the Lung Is Associated with Serum Rheumatoid Arthritis-Related Autoantibodies Even in Absence of Clinically Apparent Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/ectopic-lymphoid-tissue-in-the-lung-is-associated-with-serum-rheumatoid-arthritis-related-autoantibodies-even-in-absence-of-clinically-apparent-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ectopic-lymphoid-tissue-in-the-lung-is-associated-with-serum-rheumatoid-arthritis-related-autoantibodies-even-in-absence-of-clinically-apparent-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology